Compare Pyridam Farma Tbk (PYFA) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pyridam Farma Tbk vs Mizuho Leasing Indonesia Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp214 (market cap 2.31T, 10.47M 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp76 (market cap 432.24B, 286.8K 24h volume). The key difference: Pyridam Farma Tbk is far larger — about 5.3× Mizuho Leasing Indonesia Tbk.'s market cap, and Pyridam Farma Tbk is more actively traded (10.47M versus 286.8K). Which is the better fit depends on your goals.
| PYFA | VRNA | |
|---|---|---|
Market Cap | 2.31T | 432.24B |
Volume | 10.47M | 286.8K |
Lot | 104.73K | 2.87K |
Turnover | 2.2B | 22.19M |
Average Price | 209.71 | 77.35 |
Value | 2.2B | 22.19M |
Indicative Equilibrium Price | 214 | 76 |
Indicative Equilibrium Volume | 10.89K | 5K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pyridam Farma Tbk
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →About Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Read more on VRNA →
